Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
20 sept. 2023 09h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation of...
Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry
14 sept. 2023 09h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Seeking to expand the knowledge base surrounding spectral flow cytometry, Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis...
Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference
06 sept. 2023 16h10 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services
28 août 2023 05h30 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the appointment of Philippe Busque, Ph.D. as...
Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit
10 août 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences Reports Second Quarter 2023 Financial Results
08 août 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30,...
Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
20 juil. 2023 17h26 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the second...
Cytek Biosciences to Participate in the 44th Annual Goldman Sachs Healthcare Conference
31 mai 2023 16h05 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming...
Cytek Biosciences Announces $50 Million Stock Repurchase Program
19 mai 2023 09h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved the...
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
16 mai 2023 08h00 HE
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 16, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has shipped its 100th Cytek Aurora CS...